Atlas Trials

R-DA-EDOCH Versus R-CEOP90, With/Without Upfront Auto-HSCT in Young Patients With High-risk DLBCL

Clinical trial NCT03213977 · UNKNOWN

Trial details

NCT number
NCT03213977
Sponsor
Fujian Medical University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diffuse Large B-cell Lymphoma
Start date
2017-07-10
Primary completion
2023-07-13
Enrollment
475

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.